Akebia Therapeutics to Present at the Jefferies London Healthcare Conference
Akebia Therapeutics (Nasdaq: AKBA) has announced its participation in the upcoming Jefferies London Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Akebia Therapeutics (Nasdaq: AKBA) has announced its participation in the upcoming Jefferies London Healthcare Conference. CEO John Butler will deliver a presentation on Thursday, November 21 at 1:00 PM GMT. The conference is scheduled for November 19-21, 2024, in London. Interested parties can access the presentation webcast through the 'Investors' section of Akebia's website at ir.akebia.com, where it will remain available for 30 days after the event. Akebia Therapeutics focuses on improving the lives of people affected by kidney disease.
Details
News Market Reaction – AKBA
The recorded move for AKBA in the trading session of this news was -2.01%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 30 days following the conference.
The Jefferies London Healthcare Conference will take place November 19-21, 2024 in
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-jefferies-london-healthcare-conference-302301773.html
SOURCE Akebia Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.